AbbVie (NYSE: ABBV) and Pharmacyclics (Nasdaq: PCYC) announced a definitive agreement under which AbbVie will acquire Pharmacyclics, and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE